IMMX
Immix Biopharma Inc
7.70$
-3.8%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Immix Biopharma Inc (IMMX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/27/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 09/30/2026 | Current report (8-K) | Immix Biopharma, Inc. (IMMX): Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/29/2026 | Current report (8-K) | Immix Biopharma, Inc. (IMMX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/29/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/20/2026 | Current report (8-K) | Immix Biopharma, Inc. (IMMX): Other Events | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.